| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9326705 | Gynecologic Oncology | 2005 | 10 Pages |
Abstract
Our ongoing research and recent work performed by other laboratories highlights the potential physiologic role of this mucin. Based on the data presented here, it is likely that the tumor-derived CA125 acts as a suppressor of the immune response that is directed against the ovarian tumors.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Manish S. Patankar, Yu Jing, Jamie C. Morrison, Jennifer A. Belisle, Frank A. Lattanzio, Yuping Deng, Nyet Kui Wong, Howard R. Morris, Anne Dell, Gary F. Clark,